NCT03560440

Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 368 (actual)
• Sponsor: Universitaire Ziekenhuizen KU Leuven · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

In this retrospective registry the investigators wish to verify whether the current dosing regime of vancomycin is leading to the appropriate pharmacokinetic targets in pediatric patients. Therefore data will be collected from all pediatric patients hospitalized in University Hospitals Leuven between January 2012 and April 2014 who were treated with vancomycine.

Detailed description

In this retrospective registry the investigators wish to verify whether the current dosing regime of vancomycin is leading to the appropriate pharmacokinetic targets in pediatric patients. Therefore data will be collected from all pediatric patients hospitalized in University Hospitals Leuven between January 2012 and April 2014 who were treated with vancomycine. Patient files will be screened for relevant information. Individual patients can be included multiple times if vancomycin has been administered more than once.

Conditions

• Gram-Positive Bacterial Infections

Interventions

Type	Name	Description
OTHER	Plasma exposure vancomycin	Investigation of plasma exposure of vancomycin.

Timeline

• Start date: 2014-06-01
• Primary completion: 2016-02-01
• Completion: 2017-06-01
• First posted: 2018-06-18
• Last updated: 2018-06-18

Locations

1 site across 1 country: Belgium